Brand name: Buprenorphine (Sandoz) TM
Active ingredients: buprenorphine
What it is used for
Management of moderate to severe pain.
How to take it
The way to take this medicine is: Transdermal.
- Store below 25 degrees Celsius
- Shelf lifetime is 24 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Rectangular transdermal patch with rounded edges having transparent release liner on bottom side and pale yellowish-brown adhesive foil imprinted in black ink with Buprenorphinum 40 ug/h on upper side
Do I need a prescription?
This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.
Pregnant or planning a pregnancy?
For the active ingredient buprenorphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What it is used for
Management of moderate to severe pain.
How to take it
The way to take this medicine is: Transdermal.
- Store below 25 degrees Celsius
- Shelf lifetime is 24 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Rectangular transdermal patch with rounded edges having transparent release liner on bottom side, and pale yellowish-brown adhesive foil imprinted in black ink with Buprenorphinum 30 ug/h on upper side
Do I need a prescription?
This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.
Pregnant or planning a pregnancy?
For the active ingredient buprenorphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What it is used for
Management of moderate to severe pain.
How to take it
The way to take this medicine is: Transdermal.
- Store below 25 degrees Celsius
- Shelf lifetime is 24 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Rectangular transdermal patch with rounded edges having transparent release liner on bottom side, and pale yellowish-brown adhesive foil imprinted in black ink with Buprenorphinum 25 ug/h on upper side
Do I need a prescription?
This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.
Pregnant or planning a pregnancy?
For the active ingredient buprenorphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What it is used for
Management of moderate to severe pain.
How to take it
The way to take this medicine is: Transdermal.
- Store below 25 degrees Celsius
- Shelf lifetime is 24 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Rectangular transdermal patch with rounded edges having transparent release liner on bottom side and pale yellowish-brown adhesive foil imprinted (in black ink) with "Buprenorphinum 20 micrograms/h" on upper side
Do I need a prescription?
This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.
Pregnant or planning a pregnancy?
For the active ingredient buprenorphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What it is used for
Management of moderate to severe pain.
How to take it
The way to take this medicine is: Transdermal.
- Store below 25 degrees Celsius
- Shelf lifetime is 24 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Rectangular transdermal patch with rounded edges having transparent release liner on bottom side and pale yellowish-brown adhesive foil imprinted (in black ink) with "Buprenorphinum 20 micrograms/h" on upper side
Do I need a prescription?
This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.
Pregnant or planning a pregnancy?
For the active ingredient buprenorphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What it is used for
Management of moderate to severe pain.
How to take it
The way to take this medicine is: Transdermal.
- Store below 25 degrees Celsius
- Shelf lifetime is 24 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Rectangular transdermal patch with rounded edges having transparent release liner on bottom side and pale yellowish-brown adhesive foil imprinted (in black ink) with "Buprenorphinum 10 micrograms/h" on upper side
Do I need a prescription?
This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.
Pregnant or planning a pregnancy?
For the active ingredient buprenorphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What it is used for
Management of moderate to severe pain.
How to take it
The way to take this medicine is: Transdermal.
- Store below 25 degrees Celsius
- Shelf lifetime is 24 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Rectangular transdermal patch with rounded edges having transparent release liner on bottom side and pale yellowish-brown adhesive foil imprinted (in black ink) with "Buprenorphinum 15 micrograms/h" on upper side
Do I need a prescription?
This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December 1, 2020. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy?
For the active ingredient buprenorphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What it is used for
Management of moderate to severe pain.
How to take it
The way to take this medicine is: Transdermal.
- Store below 25 degrees Celsius
- Shelf lifetime is 24 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Rectangular transdermal patch with rounded edges having transparent release liner on bottom side and pale yellowish-brown adhesive foil imprinted (in black ink) with "Buprenorphinum 5 micrograms/h" on upper side
Do I need a prescription?
This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.
Pregnant or planning a pregnancy?
For the active ingredient buprenorphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What it is used for
Management of moderate to severe pain.
How to take it
The way to take this medicine is: Transdermal.
- Store below 25 degrees Celsius
- Shelf lifetime is 24 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Rectangular transdermal patch with rounded edges having transparent release liner on bottom side and pale yellowish-brown adhesive foil imprinted (in black ink) with "Buprenorphinum 5 micrograms/h" on upper side
Do I need a prescription?
This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December 1, 2020. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy?
For the active ingredient buprenorphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What it is used for
Management of moderate to severe pain.
How to take it
The way to take this medicine is: Transdermal.
- Store below 25 degrees Celsius
- Shelf lifetime is 24 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Rectangular transdermal patch with rounded edges having transparent release liner on bottom side and pale yellowish-brown adhesive foil imprinted (in black ink) with "Buprenorphinum 20 micrograms/h" on upper side
Do I need a prescription?
This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December 1, 2020. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy?
For the active ingredient buprenorphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What it is used for
Management of moderate to severe pain.
How to take it
The way to take this medicine is: Transdermal.
- Store below 25 degrees Celsius
- Shelf lifetime is 24 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Rectangular transdermal patch with rounded edges having transparent release liner on bottom side and pale yellowish-brown adhesive foil imprinted (in black ink) with "Buprenorphinum 10 micrograms/h" on upper side
Do I need a prescription?
This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.
Pregnant or planning a pregnancy?
For the active ingredient buprenorphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What it is used for
Management of moderate to severe pain.
How to take it
The way to take this medicine is: Transdermal.
- Store below 25 degrees Celsius
- Shelf lifetime is 24 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Rectangular transdermal patch with rounded edges having transparent release liner on bottom side and pale yellowish-brown adhesive foil imprinted (in black ink) with "Buprenorphinum 10 micrograms/h" on upper side
Do I need a prescription?
This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December 1, 2020. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy?
For the active ingredient buprenorphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What it is used for
Management of moderate to severe pain.
How to take it
The way to take this medicine is: Transdermal.
- Store below 25 degrees Celsius
- Shelf lifetime is 24 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Rectangular transdermal patch with rounded edges having transparent release liner on bottom side and pale yellowish-brown adhesive foil imprinted (in black ink) with "Buprenorphinum 5 micrograms/h" on upper side
Do I need a prescription?
This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.
Pregnant or planning a pregnancy?
For the active ingredient buprenorphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What it is used for
Management of moderate to severe pain.
How to take it
The way to take this medicine is: Transdermal.
- Store below 25 degrees Celsius
- Shelf lifetime is 24 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Rectangular transdermal patch with rounded edges having transparent release liner on bottom side and pale yellowish-brown adhesive foil imprinted (in black ink) with "Buprenorphinum 15 micrograms/h" on upper side
Do I need a prescription?
This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.
Pregnant or planning a pregnancy?
For the active ingredient buprenorphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What it is used for
Management of moderate to severe pain.
How to take it
The way to take this medicine is: Transdermal.
- Store below 25 degrees Celsius
- Shelf lifetime is 24 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Rectangular transdermal patch with rounded edges having transparent release liner on bottom side and pale yellowish-brown adhesive foil imprinted (in black ink) with "Buprenorphinum 15 micrograms/h" on upper side
Do I need a prescription?
This medicine requires authorisation for prescription from your doctor. It is Schedule 8 : Controlled Drug.
Pregnant or planning a pregnancy?
For the active ingredient buprenorphine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Download leaflet
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems